webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

γ-Amanitin

  CAS No.: 21150-23-2   Cat No.: BADC-00822   Purity: ≥95% 4.5  

γ-Amanitin is an ADC cytotoxin isolated from mushrooms. γ-Amanitin inhibits RNA polymerase II and disrupts mRNA synthesis. γ-Amanitin has similar effects to α-Amanitin and β-Amanitin.

γ-Amanitin

Structure of 21150-23-2

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Cytotoxin
Molecular Formula
C39H54N10O13S
Molecular Weight
902.97
Shipping
Room temperature, or blue ice upon request.
Storage
Store at -20°C

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
Synonyms
(1R,4S,8R,10S,13S,16S,34S)-4-(2-Amino-2-oxoethyl)-34-[(2S)-2-butanyl]-8,22-dihydroxy-13-[(2R,3S)-3-hydroxy-2-butanyl]-2,5,11,14,30,33,36,39-octaoxo-27-thionia-3,6,12,15,25,29,32,35,38-nonaazapentacyclo[14.12.11.06,10.018,26.019,24]nonatriaconta-18(26),19,21,23-tetraen-27-olate
IUPAC Name
2-[(1R,4S,8R,10S,13S,16S,34S)-34-[(2S)-butan-2-yl]-8,22-dihydroxy-13-[(2R,3S)-3-hydroxybutan-2-yl]-2,5,11,14,27,30,33,36,39-nonaoxo-27lambda4-thia-3,6,12,15,25,29,32,35,38-nonazapentacyclo[14.12.11.06,10.018,26.019,24]nonatriaconta-18(26),19(24),20,22-tetraen-4-yl]acetamide
Canonical SMILES
CCC(C)C1C(=O)NCC(=O)NC2CS(=O)C3=C(CC(C(=O)NCC(=O)N1)NC(=O)C(NC(=O)C4CC(CN4C(=O)C(NC2=O)CC(=O)N)O)C(C)C(C)O)C5=C(N3)C=C(C=C5)O
InChI
InChI=1S/C39H54N10O13S/c1-5-16(2)31-36(59)42-12-29(54)43-26-15-63(62)38-22(21-7-6-19(51)8-23(21)46-38)10-24(33(56)41-13-30(55)47-31)44-37(60)32(17(3)18(4)50)48-35(58)27-9-20(52)14-49(27)39(61)25(11-28(40)53)45-34(26)57/h6-8,16-18,20,24-27,31-32,46,50-52H,5,9-15H2,1-4H3,(H2,40,53)(H,41,56)(H,42,59)(H,43,54)(H,44,60)(H,45,57)(H,47,55)(H,48,58)/t16-,17-,18-,20+,24-,25-,26-,27-,31-,32-,63?/m0/s1
InChIKey
WVHGJJRMKGDTEC-ZUROAWGWSA-N
Density
1.5±0.1 g/cm3
Solubility
Soluble in DMSO
Flash Point
901.2±34.3 °C
Index Of Refraction
1.684
PSA
405.28000
Vapor Pressure
0.0±0.3 mmHg at 25°C
Appearance
White to Off-white Powder
Shelf Life
≥ 2 years
Shipping
Room temperature, or blue ice upon request.
Storage
Store at -20°C
Boiling Point
1566.5±65.0°C (Predicted)
In Vitro
The half-maximum inhibition concentrations (IC50) of α-amanitin, β-amanitin and γ-amanitin, and limits of detection (LODs, IC15) were 66.3, 97.4, 163.1 ng/mL and 0.91, 0.98, 0.89 ng/mL, respectively. The LODs for α-amanitin, β-amanitin and γ-amanitin in mushroom samples were 4.55, 4.9, and 4.45 ng/m.
Mechanism Of Action
In Comparison With The Phallotoxins/...The Long Delayed Hepatotoxic Response Seen In Human Poisonings...Is More Likely Due To...Alpha-, Beta-, & Gamma-Amanitin, Especially The Alpha Component. These So-Called Amatoxins...Are More Toxic Than The Phallotoxins, &, Unlike The Latter, They Damage The Nucleolus & Later The Nucleus Of Liver Cells.

γ-Amanitin is a bicyclic octapeptide and a highly potent ADC cytotoxin employed as an ADC payload in antibody-drug conjugates. Its cytotoxic mechanism involves selective and irreversible inhibition of RNA polymerase II, resulting in suppression of mRNA transcription. This disruption of gene expression leads to arrest of protein synthesis and induces apoptosis in actively proliferating tumor cells. The unique structural features of γ-Amanitin, including the tryptathionine bridge and hydroxylated residues, enable stable conjugation to monoclonal antibodies via cleavable or non-cleavable linker chemistries. These linkers are designed to maintain systemic stability while facilitating controlled intracellular payload release within targeted tumor cells.

Within antibody-drug conjugates, γ-Amanitin is covalently attached to the antibody component using linkers that provide chemical stability in circulation and enable enzymatic or chemical cleavage inside tumor cells. The ADC remains inactive during systemic circulation, preventing premature cytotoxic effects. Following internalization through receptor-mediated endocytosis, intracellular processing releases the γ-Amanitin payload, which binds to RNA polymerase II and inhibits transcription. This site-specific mechanism ensures that the cytotoxic activity is confined to antigen-expressing cells, resulting in reproducible induction of apoptosis and consistent tumor-targeted activity. The ability to control linker cleavage and payload release is critical to optimizing pharmacokinetics and minimizing off-target toxicity in ADC design.

Applications of γ-Amanitin include its integration into ADCs targeting both solid tumors and hematologic malignancies with defined antigen expression. The payload is compatible with a range of linker chemistries, allowing modulation of conjugation efficiency, intracellular release kinetics, and pharmacokinetic behavior. In preclinical models, γ-Amanitin-based ADCs demonstrate consistent cytotoxicity in RNA polymerase II-expressing tumor cells. Its defined mechanism of action, precise intracellular activity, and compatibility with diverse ADC architectures make it suitable for incorporation into mechanistically controlled tumor-targeted therapeutic constructs, supporting highly specific antitumor strategies in ADC development.

What is γ-Amanitin?

γ-Amanitin is a highly potent RNA polymerase II inhibitor derived from Amanita mushrooms, frequently utilized as an ADC payload. It selectively inhibits transcription in target cells, resulting in cell cycle arrest and apoptosis when delivered via antibody conjugates.

12/2/2022

Could you explain how γ-Amanitin enhances ADC specificity?

γ-Amanitin’s potency and mechanism allow ADCs to selectively target antigen-positive cells. The antibody facilitates precise delivery, minimizing systemic exposure and maximizing cytotoxic effect within the intended tumor population.

1/12/2018

We would like to know which linkers are compatible with γ-Amanitin.

γ-Amanitin can be conjugated via cleavable linkers responsive to intracellular conditions, such as disulfide or peptide-based linkers. These linkers ensure stable circulation and controlled release within the target cell for optimal ADC performance.

15/9/2018

Can γ-Amanitin be applied in preclinical ADC studies?

Yes, γ-Amanitin is commonly employed in preclinical ADC studies to assess cytotoxicity, pharmacokinetics, and efficacy. These studies are essential for ADC optimization and to predict clinical therapeutic potential.

2/9/2019

Good morning! What laboratory safety measures are required when handling γ-Amanitin?

Due to its extreme toxicity, γ-Amanitin handling requires strict safety protocols, including PPE, containment systems, and meticulous waste management to prevent exposure during research and conjugation procedures.

27/9/2018

— Dr. David Miller, Senior ADC Researcher (USA)

γ-Amanitin delivered by BOC Sciences had exceptional purity and stability.

15/9/2018

— Dr. William Scott, Toxicology Researcher (USA)

The γ-Amanitin supplied by BOC Sciences was of top quality, with purity levels suitable for ADC payload research.

27/9/2018

— Ms. Elisa Wagner, ADC Scientist (Germany)

We appreciated the complete analytical reports provided with γ-Amanitin, ensuring confidence in our experimental outcomes.

2/9/2019

— Dr. Robert Green, R&D Lead (UK)

γ-Amanitin was delivered on time, and its stability under storage conditions was better than expected.

12/2/2022

— Mr. Pierre Dubois, Biotech Engineer (France)

The technical support team at BOC Sciences helped us optimize the use of γ-Amanitin in our conjugation workflow.

— Dr. Helena Novak, Research Scientist (Czech Republic)

Reliable sourcing of γ-Amanitin has been critical for our project milestones, and BOC Sciences delivered consistently.

1/12/2018

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Payload Development Biological Payload Chemical Payload Protein Toxin Nanocarrier Microtubule Inhibitors DNA Damaging Agents RNA Polymerase Inhibitors Protein Degraders

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Maytansine and Its Analogues Cytotoxic Agents Used in Antibody–Drug Conjugates Exatecan Mesylate in ADCs: A New Topo I Inhibitor What is Calicheamicin? What is Monomethyl Auristatin E (MMAE)? What is Monomethyl Auristatin F (MMAF)? What is Pyrrolobenzodiazepine (PBD)? Antiviral Potential of Thapsigargin in COVID-19 Research ADC Payloads Explained: Current Types and Cutting-Edge Research Progress Tubulin Inhibitors - Highly Potential ADC Payloads

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: N-[6-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanoyl]-L-valyl-L-alanine | CL2A-Chimmitecan | Satralizumab Linker | JUN68744 | Fmoc-N-amido-PEG8-propionic acid | Fmoc-N-Me-Lys(N3)-OH | SuO-Glu-Val-Cit-PAB-MMAE | Amino-SS-PEG12-acid | Biotin-PEG4-PFP ester | Me-triacetyl-β-D-glucopyranuronate-Ph-ald-NO2 | γ-Amanitin
Send Inquiry
Verification code
Inquiry Basket